These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 944615)

  • 1. Microfluoremetric analysis of DNA content changes in murine teratocarcinoma.
    Swartzendruber DE; Cram LS; Lehman JM
    Cancer Res; 1976 Jun; 36(6):1894-9. PubMed ID: 944615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Wnt-13 is developmentally regulated during the differentiation of NTERA-2 pluripotent human embryonal carcinoma cells.
    Wakeman JA; Walsh J; Andrews PW
    Oncogene; 1998 Jul; 17(2):179-86. PubMed ID: 9674702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of the effect 5-bromodeoxyuridine on mouse teratocarcinoma cells.
    Swartzendruber DE; Travis GL; Martin JC
    Cytometry; 1980 Nov; 1(3):238-44. PubMed ID: 7021106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal lines of teratocarcinoma cells in vitro: differentiation and cytogenetic characteristics.
    McBurney MW
    J Cell Physiol; 1976 Nov; 89(3):441-55. PubMed ID: 988033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell lines derived from teratocarcinomas.
    Nicolas JF; Avner P; Gaillard J; Guenet JL; Jakob H; Jacob F
    Cancer Res; 1976 Nov; 36(11 Pt. 2):4224-31. PubMed ID: 61803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1.
    Baldassarre G; Romano A; Armenante F; Rambaldi M; Paoletti I; Sandomenico C; Pepe S; Staibano S; Salvatore G; De Rosa G; Persico MG; Viglietto G
    Oncogene; 1997 Aug; 15(8):927-36. PubMed ID: 9285688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes.
    Martin GM; Ogburn CE; Au K; Disteche CM
    J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers.
    Sell S; Pierce GB
    Lab Invest; 1994 Jan; 70(1):6-22. PubMed ID: 8302019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feulgen-DNA-values in transitional cell carcinoma of the human urinary bladder.
    Fossä SD
    Beitr Pathol; 1975 May; 155(1):44-55. PubMed ID: 1156320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine embryonal carcinoma hybrids: decreased ability to spontaneously differentiate as a dominant trait.
    Oshima RG; McKerrow J; Cox D
    J Cell Physiol; 1981 Nov; 109(2):195-204. PubMed ID: 7197684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors.
    Pera MF; Bennett W; Cerretti DP
    Lab Invest; 1997 Apr; 76(4):497-504. PubMed ID: 9111512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection.
    Andrews PW; Trinchieri G; Perussia B; Baglioni C
    Cancer Res; 1987 Feb; 47(3):740-6. PubMed ID: 3026615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teratocarcinoma stem cells as a model for differentiation in the mouse embryo.
    Lehtonen E; Laasonen A; Tienari J
    Int J Dev Biol; 1989 Mar; 33(1):105-15. PubMed ID: 2485690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of polyploid cells and G2-phase cells during ascites tumor growth.
    Andersson G
    J Cell Physiol; 1977 Feb; 90(2):329-35. PubMed ID: 838780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Of mice and men: teratomas and teratocarcinomas.
    Bulić-Jakus F; Ulamec M; Vlahović M; Sincić N; Katusić A; Jurić-Lekć G; Serman L; Kruslin B; Belicza M
    Coll Antropol; 2006 Dec; 30(4):921-4. PubMed ID: 17243571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The amount of a specific cellular protein (p53) is a correlate of differentiation in embryonal carcinoma cells.
    Chandrasekaran K; Mora PT; Nagarajan L; Anderson WB
    J Cell Physiol; 1982 Oct; 113(1):134-40. PubMed ID: 6290508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic and corresponding flow cytometric DNA analysis of renal cell neoplasms.
    el-Naggar AK; Pathak S
    Anticancer Res; 1992; 12(5):1491-500. PubMed ID: 1444211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow sorting in the study of cell-cell interaction.
    Schaap GH; Verkerk A; Vijg J; Jongkind JF
    Cytometry; 1983 May; 3(6):408-13. PubMed ID: 6851790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural differentiation of a clonal human embryonal carcinoma cell line in vitro.
    Damjanov I; Andrews PW
    Cancer Res; 1983 May; 43(5):2190-8. PubMed ID: 6187445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA content of murine fibrosarcoma cell lines with varying metastatic potential.
    McCoy JP; Schade W; Merz GE; Esch T; Varani J; Hudson JL
    Cancer Res; 1985 Nov; 45(11 Pt 2):5757-61. PubMed ID: 4053048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.